| NCT Number | NCT06962059 |
| Lead Sponsor | Abramson Cancer Center at Penn Medicine |
| Conditions | Ovarian Cancer, Genetic Predisposition to Disease |
| Enrollment | 50 participants |
| Start Date | 2025-04-21 |
| Primary Completion | 2027-01-15 (estimated) |
| Study Completion | 2027-05-25 (estimated) |
| Updated on ClinicalTrials.gov | 2026-02-05 |